90
Participants
Start Date
June 30, 2008
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
PX-866
Oral solution, dose escalation, once per day on days 1 to 5 and 8 to 12 or days 1-28 of a 28 day cycle, until progression or development of unacceptable toxicity
M.D. Anderson Cancer Center, Houston
University of Colorado Health Sciences Center, Aurora
Lead Sponsor
Cascadian Therapeutics Inc.
INDUSTRY